Pneumonia acinetobacter

2 trials MedDRA PT
2 Registered trials
0 Recruiting
2 Unique sponsors
3 Unique IMPs
2 Commercial trials
Drug classes (ATC)
— ATC code not specified 2
Mechanism of action (INN-stem analysis)
Unknown / small molecule 3 substances
Phase III: 1 Phase II: 1

Filter these 2 trials by country, sponsor, date range and more.

Open in Search → Gap analysis →
Show: 2 trials

Phase III

1 trial
  • Bioversys S.A.S. Commercial
    POLYMYXIN B SULFATE; RIFABUTIN
    2025-524092-23-00 2 countries n=58
    Pending

Phase II

1 trial
Sponsor activity
SponsorTypeTrialsPhasesRecruiting
Omnix Medical Ltd. Commercial 1 Phase II 0
Bioversys S.A.S. Commercial 1 Phase III 0
← All indication landscapes